Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 99.2% in February

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 600 shares, a drop of 99.2% from the January 31st total of 73,100 shares. Based on an average trading volume of 544,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Venus Concept Trading Down 6.6 %

VERO traded down $0.02 during trading on Thursday, reaching $0.30. 491,365 shares of the company’s stock were exchanged, compared to its average volume of 653,069. The company’s fifty day moving average price is $0.36 and its 200-day moving average price is $0.43. The firm has a market capitalization of $2.17 million, a PE ratio of -0.04 and a beta of 0.51. Venus Concept has a fifty-two week low of $0.28 and a fifty-two week high of $1.59. The company has a debt-to-equity ratio of 2.83, a quick ratio of 1.18 and a current ratio of 1.86.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.